Payden & Rygel Increases Holdings in MetLife, Inc. (NYSE:MET)

Payden & Rygel grew its stake in MetLife, Inc. (NYSE:METFree Report) by 24.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 340,900 shares of the financial services provider’s stock after buying an additional 67,400 shares during the quarter. MetLife makes up 2.2% of Payden & Rygel’s portfolio, making the stock its 7th biggest holding. Payden & Rygel’s holdings in MetLife were worth $28,117,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. First Horizon Advisors Inc. raised its holdings in MetLife by 2.8% during the third quarter. First Horizon Advisors Inc. now owns 398,242 shares of the financial services provider’s stock valued at $32,847,000 after acquiring an additional 10,676 shares during the period. Segall Bryant & Hamill LLC bought a new position in MetLife in the 3rd quarter worth approximately $1,074,000. Prospera Private Wealth LLC purchased a new stake in MetLife in the 3rd quarter worth $59,000. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of MetLife during the 3rd quarter valued at about $2,960,000. Finally, Banque Cantonale Vaudoise grew its holdings in MetLife by 426.4% during the 3rd quarter. Banque Cantonale Vaudoise now owns 51,374 shares of the financial services provider’s stock valued at $4,237,000 after buying an additional 41,615 shares in the last quarter. Institutional investors own 89.81% of the company’s stock.

MetLife Stock Down 0.0 %

Shares of MET traded down $0.04 during mid-day trading on Wednesday, hitting $82.59. 269,842 shares of the company traded hands, compared to its average volume of 3,306,500. The company has a market capitalization of $57.19 billion, a PE ratio of 16.67, a price-to-earnings-growth ratio of 0.76 and a beta of 1.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The business has a 50 day moving average of $81.92 and a 200 day moving average of $75.80. MetLife, Inc. has a 1-year low of $62.14 and a 1-year high of $86.94.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. MetLife’s payout ratio is currently 43.95%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on the stock. Piper Sandler upped their price target on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. TD Cowen initiated coverage on MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 target price on the stock. StockNews.com raised shares of MetLife from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Citigroup upped their price target on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Finally, Bank of America reduced their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. Fourteen investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $88.46.

View Our Latest Analysis on MET

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.